Frederick biotech company gets praise to go with funding

From the Frederick News-Post
By Nancy Lavin 07APR2016

The city of Frederick is putting its money where its mouth is in supporting the growing biotech industry. The Board of Aldermen on Thursday approved a $10,000 loan for BioFactura to support the company’s relocation and expansion. The city contribution will work in conjunction with a recently announced $50,000 loan from the Maryland Department of Commerce…

<Read Full Story>

April 7, 2016 BioFactura In The News

About BioFactura

BioFactura (Frederick MD) develops and commercializes high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast Biomanufacturing Platform, the optimal system for bringing these drugs to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.